EFFECT OF TAMSULOSIN ON AUA SYMPTOM SCORE AND BPH IMPACT INDEX AS A FUNCTION OF SYMPTOM SEVERITY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Introduction: Benign prostatic Hyperplasia is a common disorder and cause of morbidity in the ageing men. The evaluation symptoms and the bother associated with it are important for management. International Prostate Symptom Score (IPSS), Quality of life (QOL) and Benign Prostatic Hyperplasia Impact Index (BII) are practiced to quantify the severity of the disease. The size of prostate gland does not correlate with lower urinary tract symptoms. Correlation among above scoring is also not clear. Aim of the study is to evaluate correlation of prostate volume with International Prostate Symptom Score, Benign Prostatic Hyperplasia Impact Index and prostate size.Methods: Prospective study. Ninety-eight patients were included. Patients were assessed preoperatively with the International Prostate Symptom Score, Benign Prostatic Hyperplasia Impact Index and prostate volumes by trans abdominal ultrasound.Results: The mean age was 66.7 ± 7.3 years (50- 84) the mean IPSS, QOL, BII and prostate volumes were 23.6 ±6.0, 5.1 ± 0.9, 7.1±2.4 and 47.5±16.63 respectively. There was positive correlation between the IPSS and BII, IPSS and QOL and BII and QOL (rs= 0.89, 0.585 and 0.530 respectively) and no correlation between IPSS and BII with prostatic weight. (rs= -0.04 and -0.07 respectively).Conclusion: Management of the benign prostate hyperplasia should be considered on the bother symptoms and not on the size of the prostate.Journal of Society of Surgeons of Nepal Vol.17(1) 2014: 6-10

Download Full-text

Simplified Chinese Version of the International Prostate Symptom Score and the Benign Prostatic Hyperplasia Impact Index: Cross-Cultural Adaptation, Reliability, and Validity for Patients with Benign Prostatic Hyperplasia

10.21203/rs.3.rs-1209172/v1 ◽

2021 ◽

Author(s):

Rong-liang Dun ◽

Jian-min Mao ◽

Chao Yu ◽

Qiang Zhang ◽

Xiao-hua Hu ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Symptom Score ◽

Prostatic Hyperplasia ◽

Cross Cultural ◽

Chinese Patients ◽

Retest Reliability ◽

Simplified Chinese ◽

Impact Index ◽

Sf 36 ◽

Test Retest Reliability

Abstract Purpose: The aim of this study was to translate and cross-cultural adapt the international prostate symptom score (IPSS) and benign prostatic hyperplasia impact index (BII) into simplified Chinese for mainland Chinese patients with benign prostatic hyperplasia (BPH).Methods: The original English IPSS and BII were translated into simplified Chinese versions, based on cross-cultural adaptation guidelines. Internal consistency was evaluated with Cronbach’ α, then test-retest reliability with intraclass correlation coefficients (ICCs) in stable patients. The validity of these two adaptations was tested by the correlation between the IPSS, and BII with visual prostate symptom score (VPSS), and 36 items Short Form Health Survey (SF-36). The floor and ceiling effects were calculated by the proportion of participants who obtained the highest and lowest possible score.Results: A total of 105 native Chinese-speaking patients with BPH were enrolled. Cronbach’ α were over 0.75 for the simplified Chinese IPSS (IPSS 0.815; IPSS-symptom 0.782), and 0.709 for the simplified Chinese BII, indicating acceptable internal consistency. The ICCs for the test-retest reliability were over 0.75 (IPSS, r = 0.836; IPSS-symptom, r = 0.801; IPSS-quality of life, r = 0.794; BII, r = 0.758), indicating excellent test-retest reliability. There were very good positive correlations between IPSS and BII (r = 0.605), as well as VPSS (r = 0.634), and very good or good negative correlations between IPSS-Qol and SF-36 physical functioning (r = -0.621), and vitality (r = -0.659), and between BII and SF-36 physical functioning (r = -0.421). No floor or ceiling effect was detected in the simplified Chinese IPSS and BII.Conclusions: This study indicates that the simplified Chinese IPSS and BII are reliable and valid measurement of the symptom and quality of life among Chinese patients with BPH, which is likely to be widely used in this population.

Download Full-text